Both procedures reduced healthcare costs and complications, measured in extra visits, for people with type 2 diabetes in the months immediately after surgery. Four years later, however, healthcare costs and complications increased for patients who had bypass surgery but continued to decline for those who received banding.
Allergan, maker of the Lap-Band laparoscopic gastric banding device, funded the study, which was presented at the annual meeting of the American Diabetes Association.
Read the WebMD report on gastric banding.
Related Articles on Weight Loss Surgery:
Discharge One Day After Gastric Bypass Linked to Higher Mortality
Some Providers Widen BMI Limits for Gastric Banding After FDA Decision
Study: Gastric Bypass Can Help Fight Cancer, Diabetes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.